Sanofi sees strong profit growth from 2018, to cut costs
November 06, 2015 at 01:22 AM EST
PARIS, Nov 6 (Reuters) - Sanofi said investment in products to compensate for declining diabetes sales will prevent significant profit growth in the next two years, adding that earnings would outpace sales from 2018.
